Associate Director, Specialty Bioanalytics, Automation
Teva Branded Pharmaceutical Products, Inc.
West Chester, Pennsylvania
Mary Belfast has experience in bioassay method development, R&D and process development, advancing many pharmaceutical small molecules, vaccines and biologic modalities from discovery through clinical development. Currently, she leads the Specialty Bioanalytics, Laboratory Automation group at Teva Branded Pharmaceuticals focused on the seamless transition from manual assay processes to automated platforms and automating data processing using RPA/AI technologies. Recent projects include automation of ADA methods, LBA methods, standardizing calculations for critical platforms and reducing time required for writing Assay Validation Reports. Mary also serves as the vice-chair to the AAPS AI/ML Robotics in Regulated Bioanalytical Laboratories team supporting shaping industry standards and fostering innovation in bioanalytical practices.
Disclosure information not submitted.
Keynote: Applying AI/ML Methodologies Within Regulated Bioanalysis
Monday, October 21, 2024
1:30 PM – 2:30 PM MT